Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TICAGRELOR, with a corresponding US DMF Number 36701.
Remarkably, this DMF maintains an Active status since its submission on January 27, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 21, 2022, and payment made on February 18, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II